MYRIAD GENETICS INC — Director's Dealing 2013

May 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2013-05-08

Reporting Person: MELDRUM PETER D (Director, President & C.E.O.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-08	Common Stock	M	3938	$7.82	Acquired	89250	Direct
2013-05-08	Common Stock	S	3938	$31	Disposed	85312	Direct
2013-05-10	Common Stock	M	22022	$7.82	Acquired	107334	Direct
2013-05-10	Common Stock	S	22022	$31	Disposed	85312	Direct
2013-05-10	Common Stock	M	25000	$7.82	Acquired	110312	Direct
2013-05-10	Common Stock	S	25000	$32	Disposed	85312	Direct
2013-05-10	Common Stock	M	25000	$7.82	Acquired	110312	Direct
2013-05-10	Common Stock	S	25000	$33	Disposed	85312	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-08	Non-Qualified Stock Option (right to buy)	$7.82	M	3938	Disposed	2015-02-17	Common Stock (3938)	Direct
2013-05-10	Non-Qualified Stock Option (right to buy)	$7.82	M	22022	Disposed	2015-02-17	Common Stock (22022)	Direct
2013-05-10	Non-Qualified Stock Option (right to buy)	$7.82	M	25000	Disposed	2015-02-17	Common Stock (25000)	Direct
2013-05-10	Non-Qualified Stock Option (right to buy)	$7.82	M	25000	Disposed	2015-02-17	Common Stock (25000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.